Aptevo Therapeutics Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-269598
- Form type
- 10-Q
- CIK
- 0001671584
- Primary document
- https://www.sec.gov/Archives/edgar/data/1671584/000119312525269598/apvo-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aptevo Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-20.3M | - | - |
| Net Income | $-20.2M | - | - |
| Eps Basic | -11.42 | - | - |
| Eps Diluted | -11.42 | - | - |
| Cash And Equivalents | $21.1M | - | - |
| Total Assets | $27.0M | - | - |
| Total Liabilities | $9.6M | - | - |
| Shareholders Equity | $17.4M | - | - |
| Operating Cash Flow | $-20.4M | - | - |